BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27576439)

  • 21. Antibacterial effects of the urushiol component in the sap of the lacquer tree (Rhus verniciflua Stokes) on Helicobacter pylori.
    Suk KT; Baik SK; Kim HS; Park SM; Paeng KJ; Uh Y; Jang IH; Cho MY; Choi EH; Kim MJ; Ham YL
    Helicobacter; 2011 Dec; 16(6):434-43. PubMed ID: 22059394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of clarithromycin against intracellular Helicobacter pylori.
    Piccolomini R; Di Bonaventura G; Picciani C; Laterza F; Vecchiet J; Neri M
    Antimicrob Agents Chemother; 2001 May; 45(5):1568-71. PubMed ID: 11302831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eradication of Helicobacter pylori through the inhibition of urease and peptide deformylase: Computational and biological studies.
    Saravanakumar K; Chellia R; Hu X; Kathiresan K; Oh DH; Wang MH
    Microb Pathog; 2019 Mar; 128():236-244. PubMed ID: 30611769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori.
    Paraschos S; Magiatis P; Mitakou S; Petraki K; Kalliaropoulos A; Maragkoudakis P; Mentis A; Sgouras D; Skaltsounis AL
    Antimicrob Agents Chemother; 2007 Feb; 51(2):551-9. PubMed ID: 17116667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clerodane-type diterpenoids from tuberous roots of Tinospora sagittata (Oliv.) Gagnep.
    Zhang G; Ma H; Hu S; Xu H; Yang B; Yang Q; Xue Y; Cheng L; Jiang J; Zhang J; Wang F; Zhang Y
    Fitoterapia; 2016 Apr; 110():59-65. PubMed ID: 26924160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial Characterization of Inula britannica against Helicobacter pylori on Gastric Condition.
    Lee YH; Lee NK; Paik HD
    J Microbiol Biotechnol; 2016 Jun; 26(6):1011-7. PubMed ID: 26907756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroprotective action of the extract of Corydalis yanhusuo in Helicobacter pylori infection and its bioactive component, dehydrocorydaline.
    Wu H; Sun Q; Dong H; Qiao J; Lin Y; Yu C; Li Y
    J Ethnopharmacol; 2023 May; 307():116173. PubMed ID: 36681166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Helicobacter pylori activity of Terminalia macroptera root.
    Silva O; Viegas S; de Mello-Sampayo C; Costa MJ; Serrano R; Cabrita J; Gomes ET
    Fitoterapia; 2012 Jul; 83(5):872-6. PubMed ID: 22465506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity of grape extracts on cagA-positive and -negative Helicobacter pylori clinical isolates.
    Martini S; D'Addario C; Braconi D; Bernardini G; Salvini L; Bonechi C; Figura N; Santucci A; Rossi C
    J Chemother; 2009 Nov; 21(5):507-13. PubMed ID: 19933041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Helicobacter pylori activity of bioactive components isolated from Hericium erinaceus.
    Liu JH; Li L; Shang XD; Zhang JL; Tan Q
    J Ethnopharmacol; 2016 May; 183():54-58. PubMed ID: 26364939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volatile compounds in the stem bark of Sclerocarya birrea (Anacardiaceae) possess antimicrobial activity against drug-resistant strains of Helicobacter pylori.
    Njume C; Afolayan AJ; Green E; Ndip RN
    Int J Antimicrob Agents; 2011 Oct; 38(4):319-24. PubMed ID: 21752604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.
    Hirata Y; Ohmae T; Yanai A; Sakitani K; Hayakawa Y; Yoshida S; Sugimoto T; Mitsuno Y; Akanuma M; Yamaji Y; Ogura K; Maeda S; Koike K
    Int J Antimicrob Agents; 2012 Apr; 39(4):352-5. PubMed ID: 22321702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003.
    Watanabe K; Tanaka A; Imase K; Tokunaga K; Sugano H; Kai A; Ishida H; Itoh T; Takahashi S
    Helicobacter; 2005 Feb; 10(1):4-11. PubMed ID: 15691310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
    Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aqueous and organic solvent-extracts of selected south African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: inhibitory and bactericidal potential.
    Njume C; Jide AA; Ndip RN
    Int J Mol Sci; 2011; 12(9):5652-65. PubMed ID: 22016616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia.
    Tüzün Y; Bayan K; Yilmaz S; Dursun M; Ozekinci T
    Hepatogastroenterology; 2008; 55(81):289-93. PubMed ID: 18507127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.